Despite the utilization of AFP for detection and screening for HCC, it is a very imperfect biomarker with a sensitivity for early HCC of 39%–64%, specificity of 76%–97%, and positive predictive values of 25% at 5% disease prevalence.1, 9, 43, 44. Here, AFP is linked to hepatocellular carcinoma.